[ICU acquired neuromyopathy]. - Université de Bretagne Occidentale Access content directly
Journal Articles Annales Françaises d'Anesthésie et de Réanimation Year : 2013

[ICU acquired neuromyopathy].

G. Gueret
  • Function : Author
Maïté Guillouët
  • Function : Author
V. Vermeersch
  • Function : Author
Hélène Talarmin
B.-V. Nguyen
  • Function : Author
François Rannou
  • Function : Author
M.-A. Giroux-Metges
  • Function : Author
J.-P. Pennec
  • Function : Author

Abstract

ICU acquired neuromyopathy (IANM) is the most frequent neurological pathology observed in ICU. Nerve and muscle defects are merged with neuromuscular junction abnormalities. Its physiopathology is complex. The aim is probably the redistribution of nutriments and metabolism towards defense against sepsis. The main risk factors are sepsis, its severity and its duration of evolution. IANM is usually diagnosed in view of difficulties in weaning from mechanical ventilation, but electrophysiology may allow an earlier diagnosis. There is no curative therapy, but early treatment of sepsis, glycemic control as well as early physiotherapy may decrease its incidence. The outcomes of IANM are an increase in morbi-mortality and possibly long-lasting neuromuscular abnormalities as far as tetraplegia.

Dates and versions

hal-00881574 , version 1 (08-11-2013)

Identifiers

Cite

G. Gueret, Maïté Guillouët, V. Vermeersch, E. Guillard, Hélène Talarmin, et al.. [ICU acquired neuromyopathy].. Annales Françaises d'Anesthésie et de Réanimation, 2013, 32 (9), pp.580-91. ⟨10.1016/j.annfar.2013.05.011⟩. ⟨hal-00881574⟩
116 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More